In order to further implement the Intellectual Property Power Enterprise Cultivation Project, and establish the "Suzhou Intellectual Property Power Enterprise Cultivation Project Management Platform", the Suzhou Market Supervision Administration (Suzhou Intellectual Property Office) recently released the fourth batch of enterprise list for the Suzhou Intellectual Property Power Enterprise Cultivation Project.magAssist Successfully Selected into Suzhou City's List of Intellectual Property Advantageous Enterprises with Its Sound Intellectual Property Management System and Abundant Patent Achievements.
The Intellectual Property Strong Enterprises Cultivation Project aims to enhance the core competitiveness of enterprises, with the goal of nurturing a group of leading enterprises that are landmarks in intellectual property. This effort is intended to support high-quality economic development through robust intellectual property initiatives.magAssist has won the "2023 China Outstanding Intellectual Property Management Team”、“List of Key Intellectual Property Enterprises for Protection in Suzhou City, Fourth Batch, 2023" and many other intellectual property-related honors! As an innovative enterprise in the field of life support that integrates research, production, and sales, magAssist has been committed to exploring cutting-edge technologies and product transformation while establishing a sound intellectual property management system. To date, it has applied for over300 unitsPatents, nearly new applications for patents at home and abroad in the past two years200 Pieces, with international patent layouts in major countries such as the United States and Europe, providing important intellectual property reserves and strategic support for the international development of independent innovation enterprises.magAssist Starts from Heart Failure, Building a Multi-Organ Life Support Platform. The currently released product line mainly includes the fully magnetically suspended external artificial heart MoyoAssist.® Extra VAD®Minimally Invasive Interventional Artificial Heart NyokAssist®pVAD and the New Generation Extracorporeal Membrane Oxygenation System BreathMo®ECMO, these products are at different stages respectively,MoyoAssist® Extra VAD®Approved for marketing by NMPA in April this year; NyokAssist®pVAD has successively obtained the FDA "Breakthrough Device" designation and NMPA Innovative Medical Device designation, and is currently undergoing clinical trials; BreathMo®ECMO has completed clinical trials and was awarded the Jiangsu Province Science and Technology Achievement Transformation Project in 2023. In the future, magAssist will continue to focus on intellectual property rights, transforming the power of intellectual property into more cutting-edge technologies and products that save lives.
- END -
The content of this article is solely for the purpose of information transmission or industry exchange. No content should be regarded as advertising, representing no explicit or implicit advertisement, nor should it be considered as any promise of sale or sales purpose. For accurate information, the audience is advised to consult professional medical institutions.
